Literature DB >> 6594233

Imipenem/cilastatin.

M Barza.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6594233     DOI: 10.1007/bf02017374

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  30 in total

1.  A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.

Authors:  G B Calandra; M Hesney; C Grad
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 2.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

3.  Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.

Authors:  R Auckenthaler; W R Wilson; A J Wright; J A Washington; D T Durack; J E Geraci
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

4.  Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci.

Authors:  R M Blumenthal; R Raeder; C D Takemoto; E H Freimer
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

5.  Susceptibility of anaerobic bacteria to imipenem.

Authors:  F P Tally; N V Jacobus
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790

6.  Imipenem versus moxalactam in the treatment of serious infections.

Authors:  L J Eron; D L Hixon; C H Park; R I Goldenberg; D M Poretz
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

Review 7.  Pharmacokinetic and bacteriological correlations between antimicrobial therapy of experimental meningitis in rabbits and meningitis in humans: a review.

Authors:  G H McCracken
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790

Review 8.  Thienamycin: development of imipenen-cilastatin.

Authors:  F M Kahan; H Kropp; J G Sundelof; J Birnbaum
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790

9.  In-vitro activity of MK0787 (N-formimidoyl thienamycin) against Pseudomonas aeruginosa and other Gram-negative organisms and its stability to their beta-lactamases.

Authors:  D M Livermore; R J Williams; J D Williams
Journal:  J Antimicrob Chemother       Date:  1981-11       Impact factor: 5.790

10.  Susceptibility of Legionella spp. to imipenem and 27 other beta-lactam antibiotics.

Authors:  G Ruckdeschel; W Ehret; A Ahl
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

View more
  2 in total

Review 1.  Cephalosporins 1945-1986.

Authors:  E P Abraham
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  Renal tolerance of imipenem/cilastatin and other beta-lactam antibiotics in rats.

Authors:  K Sack; J Herhahn; R Marre; E Schulz
Journal:  Infection       Date:  1985       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.